Item 15. Exhibits, Financial Statement Schedules
The following information required under this item is filed as part of this report:
a) (1) Financial Statements
- Consolidated Statements of Operations for the Years Ended February 1, 2025, February 3, 2024, and January 28, 2023
- Consolidated Statements of Comprehensive Income for the Years Ended February 1, 2025, February 3, 2024, and January 28, 2023
- Consolidated Statements of Financial Position as of February 1, 2025, and February 3, 2024
- Consolidated Statements of Cash Flows for the Years Ended February 1, 2025, February 3, 2024, and January 28, 2023
- Consolidated Statements of Shareholders’ Investment for the Years Ended February 1, 2025, February 3, 2024, and January 28, 2023
- Notes to Consolidated Financial Statements
- Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements (PCAOB ID: 42)
(2) Financial Statement Schedules
None.
Other schedules have not been included either because they are not applicable or because the information is included elsewhere in this Report.
(3) Exhibits
See exhibits listed under part (b) below.
b) Exhibits(1)
3.1 |
| |
3.2 |
| |
4.1 |
| |
4.1.1 |
| |
4.2 |
| |
10.1 | * | |
10.2 | * | |
10.3 | * | |
10.3.1 | * | |
10.4 | * | |
10.4.1 | * | |
10.4.2 | * | |
10.4.3 | * | |
10.4.4 | * | |
10.4.5 | * ** | |
10.4.6 | * ** | |
10.5 | * | |
10.6 | * | |
10.7 | * | |
10.7.1 | * | |
10.8 | * | |
10.9 | * ** | |
10.10 | * | |
10.11 | * | |
10.12 | * | |
10.13 | * | |
10.14 | * | |
10.15 | * | |
10.15.1 | * | |
10.15.2 | * | |
10.15.3 | * | |
10.16 | * | |
10.17 | *&²Ô²ú²õ±è;‡ | |
10.18 | * | |
10.19 |
| |
10.19.1 | ‡ | |
10.19.2 |
| |
10.20 | ‡ | |
10.21 | ** + ‡ | |
10.21.1 | ** + | |
10.21.2 | ** + | |
10.21.3 | + | |
10.21.4 | + | |
10.22 | ** + ‡ | |
10.22.1 | ** + | |
10.22.2 |
| |
19.1 | ** | |
21.1 | ** | |
23.1 | ** | |
24.1 | ** | |
31.1 | ** | |
31.2 | ** | |
32.1 | *** | |
32.2 | *** | |
97.1 |
| |
101.INS | ** | Inline XBRL Instance Document |
101.SCH | ** | Inline XBRL Taxonomy Extension Schema |
101.CAL | ** | Inline XBRL Taxonomy Extension Calculation Linkbase |
101.DEF | ** | Inline XBRL Taxonomy Extension Definition Linkbase |
101.LAB | ** | Inline XBRL Taxonomy Extension Label Linkbase |
101.PRE | ** | Inline XBRL Taxonomy Extension Presentation Linkbase |
104 | ** | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* | Management contract or compensatory plan or arrangement. |
** | Filed herewith. |
*** | Furnished herewith. |
+ | Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Corporation agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request. |
‡ | Certain schedules and attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Corporation agrees to furnish a copy of such schedules and attachments to the Securities and Exchange Commission upon its request. |
(1) | Certain instruments defining the rights of holders of long-term debt securities of the Corporation have been omitted pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K. The Corporation agrees to furnish copies of any such instruments to the Securities and Exchange Commission upon its request. |